Success Metrics

Clinical Success Rate
75.0%

Based on 93 completed trials

Completion Rate
75%(93/124)
Active Trials
3(2%)
Results Posted
68%(63 trials)
Terminated
31(20%)

Phase Distribution

Ph phase_2
39
25%
Ph phase_1
19
12%
Ph phase_3
27
17%
Ph early_phase_1
1
1%
Ph not_applicable
39
25%
Ph phase_4
30
19%

Phase Distribution

20

Early Stage

39

Mid Stage

57

Late Stage

Phase Distribution155 total trials
Early Phase 1First-in-human
1(0.6%)
Phase 1Safety & dosage
19(12.3%)
Phase 2Efficacy & side effects
39(25.2%)
Phase 3Large-scale testing
27(17.4%)
Phase 4Post-market surveillance
30(19.4%)
N/ANon-phased studies
39(25.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

68.4%

93 of 136 finished

Non-Completion Rate

31.6%

43 ended early

Currently Active

3

trials recruiting

Total Trials

155

all time

Status Distribution
Active(3)
Completed(93)
Terminated(43)
Other(16)

Detailed Status

Completed93
Terminated31
unknown16
Withdrawn12
Active, not recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
155
Active
3
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.6%)
Phase 119 (12.3%)
Phase 239 (25.2%)
Phase 327 (17.4%)
Phase 430 (19.4%)
N/A39 (25.2%)

Trials by Status

completed9360%
recruiting11%
withdrawn128%
active_not_recruiting21%
terminated3120%
unknown1610%

Recent Activity

Clinical Trials (155)

Showing 20 of 155 trialsScroll for more
NCT02968212Phase 2

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)

Active Not Recruiting
NCT02647723Not Applicable

Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation

Active Not Recruiting
NCT01489813Phase 2

Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment

Completed
NCT02403284Phase 4

The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

Completed
NCT06468254Phase 2

An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer

Recruiting
NCT04210713Phase 1

Neuroimmune Dysfunction in Alcohol Use Disorder

Completed
NCT04365088Phase 4

Evaluation of the Effects of Pre-operative Deflazacort on Post-operative Pain, Edema and Trismus

Unknown
NCT00967005Phase 2

N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers

Completed
NCT01341080Phase 2

Varenicline for Gait and Balance Impairment in Parkinson Disease

Completed
NCT02118610Not Applicable

Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity

Completed
NCT00838981Phase 1

Pharmacotherapy & CM for Opioid and Cocaine Dependence

Completed
NCT01913912Phase 3

Event Rate and Effects of Stimulants in ADHD

Withdrawn
NCT02137252Phase 2

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Terminated
NCT02942888Not Applicable

The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition

Completed
NCT02536417Phase 3

Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients

Completed
NCT02112643Phase 3

Selenium in Mild Thyroid Eye Disease in North America

Withdrawn
NCT02233582Phase 1

Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude

Completed
NCT01361633Phase 2

The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly

Completed
NCT00867789Not Applicable

Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department

Terminated
NCT02448654Not Applicable

Treatment for Nicotine Addiction in Women

Completed

Drug Details

Intervention Type
OTHER
Total Trials
155